Paper · 7794076
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
Yeo CJ and 8 others. Ann Surg, 1995. Cited by 881 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Papers, record 7794076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7794076
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Pancreatic Neoplasms | Major topic |
| Pancreaticoduodenectomy | Major topic |
| Actuarial Analysis | |
| Aged | |
| Chemotherapy, Adjuvant | |
| Combined Modality Therapy | |
| DNA, Neoplasm | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Multivariate Analysis | |
| Radiotherapy, Adjuvant | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-CA56130 | NCI NIH HHS | United States | R01CA056130 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,943,594 | Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. | Am J Surg | 1994 | https://conductscience.org/library/papers/7943594 | PubMed |
| 2 | 7,826,160 | The effects of regionalization on cost and outcome for one general high-risk surgical procedure. | Ann Surg | 1995 | https://conductscience.org/library/papers/7826160 | PubMed |
| 3 | 1,348,201 | Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. | Br J Surg | 1992 | https://conductscience.org/library/papers/1348201 | PubMed |
| 4 | 1,514,162 | Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. | Surg Gynecol Obstet | 1992 | https://conductscience.org/library/papers/1514162 | PubMed |
| 5 | 8,380,315 | Prognostic indicators for survival after resection of pancreatic adenocarcinoma. | Am J Surg | 1993 | https://conductscience.org/library/papers/8380315 | PubMed |
| 6 | 8,431,848 | A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma. | Cancer | 1993 | https://conductscience.org/library/papers/8431848 | PubMed |
| 7 | 8,094,952 | Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. | Ann Surg | 1993 | https://conductscience.org/library/papers/8094952 | PubMed |
| 8 | 8,098,202 | One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. | Ann Surg | 1993 | https://conductscience.org/library/papers/8098202 | PubMed |
| 9 | 8,098,206 | Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. | Arch Surg | 1993 | https://conductscience.org/library/papers/8098206 | PubMed |
| 10 | 8,101,073 | Intraoperative radiation therapy following pancreaticoduodenectomy. | Ann Surg | 1993 | https://conductscience.org/library/papers/8101073 | PubMed |
1 to 10 of 43
See all 43 referencesCited by310
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 881 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,512,359 | The Progress of Pancreatectomy for Pancreatic Cancer Treatment-Lessons Learned and Future Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512359 | PubMed |
| 41,356,429 | Can Symptom Clusters Predict Stage, Resectability, and Survival in Pancreatic Cancer? | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/41356429 | PubMed |
| 41,153,675 | First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study. | Biomedicines | 2025 | https://conductscience.org/library/papers/41153675 | PubMed |
| 40,697,437 | Neoadjuvant therapy versus upfront surgery approach in resectable pancreatic cancer: a systematic review and meta-analysis. | Ann Gastroenterol | 2025 | https://conductscience.org/library/papers/40697437 | PubMed |
| 40,001,347 | Tumor immune microenvironment alterations associated with progression in human intraductal papillary mucinous neoplasms. | J Pathol | 2025 | https://conductscience.org/library/papers/40001347 | PubMed |
| 39,407,151 | Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39407151 | PubMed |
| 38,698,688 | Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer. | Cancer Med | 2024 | https://conductscience.org/library/papers/38698688 | PubMed |
| 38,046,103 | Preoperative nutritional support in patients undergoing pancreatic surgery affects PREPARE score accuracy. | Front Surg | 2023 | https://conductscience.org/library/papers/38046103 | PubMed |
| 37,760,400 | Earlier Diagnosis of Pancreatic Cancer: Is It Possible? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760400 | PubMed |
| 37,635,830 | Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type. | Ann Surg Open | 2021 | https://conductscience.org/library/papers/37635830 | PubMed |
1 to 10 of 310
See all 310 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7794076
GET https://conductscience.org/api/papers/v1/7794076/references?page=2